CORICIDIN HBP MAXIMUM STRENGTH FLU OTC
Generic Name and Formulations:
Acetaminophen 500mg, chlorpheniramine maleate 2mg, dextromethorphan HBr 15mg; tabs.
Bayer Corp, Consumer Care Div.
Indications for CORICIDIN HBP MAXIMUM STRENGTH FLU:
Cough, pain, headache, fever, rhinorrhea.
2 tabs every 6 hours; max 8 tabs/day.
Within 14 days of MAOIs. Concomitant other acetaminophen products.
Liver disease. Glaucoma. GI or GU obstruction. Asthma. Lower respiratory disorders.
Analgesic + antihistamine + antitussive.
See Contraindications. Increased risk of liver damage with ≥3 alcoholic drinks/day. Hypertensive crisis with MAOIs. Other CNS depressants potentiated.
Drowsiness, anticholinergic effects, excitability in children.
Endocrinology Advisor Articles
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- New Romosozumab BLA Includes Data from Additional Osteoporosis Trials
- Impact of Maternal Diabetes on Outcomes in Very Preterm, Very Low-Birth-Weight Infants
- Age-Related Differences in Manifestation of Cushing Disease Identified